Your browser doesn't support javascript.
loading
Actinic Keratosis: Current Therapies and Insights Into New Treatments
J Drugs Dermatol ; 18(5): s161-166., 2019 May 01.
Article in En | MEDLINE | ID: mdl-31141862
Actinic keratosis (AK) develops on chronically sun-exposed skin and constitutes one of the most common diseases managed by dermatologists. The incidence of AKs continues to rise among aging as well as younger sun damaged populations worldwide, underscoring the importance of effective therapy options. Various treatments are available, including light-based therapies, topical therapies, and destructive therapies. Herein, we review the current management options for AKs and discuss emerging therapeutic agents. J Drugs Dermatol. 2019;18(5 Suppl 1):s161-166.
Subject(s)
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Keratosis, Actinic Limits: Humans Language: En Journal: J Drugs Dermatol Journal subject: DERMATOLOGIA Year: 2019 Type: Article
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Keratosis, Actinic Limits: Humans Language: En Journal: J Drugs Dermatol Journal subject: DERMATOLOGIA Year: 2019 Type: Article